Список литературы к главе 8

1. Macintosh M.C., Fleming K.M., Bailey J.A., Doyle P., Modder J., Acolet D. et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study // BMJ. 2006. Vol. 333. P. 177–182. DOI: 10.1136/bmj.38856.692986.AE.

2. Капустин Р.В., Аржанова О.Н., Беспалова О.Н., Ковалева Т.Г. Современные представления о тактике родоразрешения беременных с гестационным сахарным диабетом // Журнал акушерства и женских болезней. 2014. Т. 6, № 4. С. 4–16. DOI: 10.17816/JOWD6344-16.

3. Mondestin M.A., Ananth C.V., Smulian J.C., Vintzileos A.M. Birth weight and fetal death in the United States: the effect of maternal diabetes during pregnancy // Am. J. Obstet. Gynecol. 2002. Vol. 187, N 4. P. 922–926. DOI: 10.1067/mob.2002.127458.

4. Overland E.A., Vatten L.J., Eskild A. Risk of shoulder dystocia: associations with parity and offspring birthweight. A population study of 1 914 544 deliveries // Acta. Obstet. Gynecol. Scand. 2012. Vol. 91, N 4. P. 483–448. DOI: 10.1111/j.1600-0412.2011.01354.x.

5. Naylor C.D., Sermer M., Chen E., Sykora K. Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? Toronto Trihospital Gestational Diabetes Investigators // JAMA. 1996. Vol. 275, N 15. P. 1165–1170.

6. Oken E., Kleinman K.P., Rich-Edwards J., Gillman M.W. A nearly continuous measure of birth weight for gestational age using a United States national reference // BMC Pediatr. 2003. Vol. 3. P. 6. DOI: 10.1186/1471-2431-3-6.

7. Evers I.M., de Valk H.W., Visser G.H. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands // BMJ. 2004. Vol. 328, N 7445. P. 915. DOI: 10.1136/bmj.38043.583160.EE.

8. Jensen D.M., Damm P., Moelsted-Pedersen L., Ovesen P., Westergaard J.G., Moeller M., Beck-Nielsen H. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study // Diabetes Care. 2004. Vol. 27, N 12. P. 2819–2823. DOI: 10.2337/diacare.27.12.2819.

9. Balsells M., García-Patterson A., Gich I., Corcoy R. Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis // J. Clin. Endocrinol. Metab. 2009. Vol. 94, N 11. P. 4284–4291. DOI: 10.1210/jc.2009-1231.

10. Айламазян Э.К., Абашова Е.И., Коган И.Ю. и др. Сахарный диабет и репродуктивная система женщины: руководство для врачей. Москва: ГЭОТАР-Медиа, 2019. 432 с.

11. Young B.C., Ecker J.L. Fetal macrosomia and shoulder dystocia in women with gestational diabetes: risks amenable to treatment? // Curr. Diabet. Rep. 2013. Vol. 13, N 1. P. 12–18. DOI: 10.1007/s11892-012-0338-8.

12. Wendland E.M., Torloni M.R., Falavigna M., Trujillo J., Dode M.A., Campos M.A. et al. Gestational diabetes and pregnancy outcomes — a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria // BMC Pregnancy Childbirth. 2012. Vol. 12. P. 23. DOI: 10.1186/1471-2393-12-23.

13. Waters T.P., Dyer A.R., Scholtens D.M., Dooley S.L., Herer E., Lowe L.P. et al. Maternal and neonatal morbidity for women who would be added to the diagnosis of GDM using IADPSG criteria: a secondary analysis of the hyperglycemia and adverse pregnancy outcome study // Diabetes Care. 2016. Vol. 39, N 12. P. 2204–2210. DOI: 10.2337/dc16-1194.

14. HAPO Study Cooperative Research Group, Metzger B.E., Lowe L.P., Dyer A.R., Trimble E.R., Chaovarindr U. et al. Hyperglycemia and adverse pregnancy outcomes // N. Engl. J. Med. 2008. Vol. 358, N 19. P. 1991–2002. DOI: 10.1056/NEJMoa0707943.

15. Chauhan S.P., Grobman W.A., Gherman R.A., Chauhan V.B., Chang G., Magann E.F., Hendrix N.W. Suspicion and treatment of the macrosomic fetus: a review // Am. J. Obstet. Gynecol. 2005. Vol. 193, N 2. P. 332–346. DOI: 10.1016/j.ajog.2004.12.020.

16. Coomarasamy A., Connock M., Thornton J., Khan K.S. Accuracy of ultrasound biometry in the prediction of macrosomia: a systematic quantitative review // BJOG. 2005. Vol. 112, N 11. P. 1461–1466. DOI: 10.1111/j.1471-0528.2005.00702.x.

17. Scifres C.M., Feghali M., Dumont T., Althouse A.D., Speer P., Caritis S.N., Catov J.M. Large-for-gestational-age ultrasound diagnosis and risk for cesarean delivery in women with gestational diabetes mellitus // Obstet. Gynecol. 2015. Vol. 126, N 5. P. 978–986. DOI: 10.1097/AOG.0000000000001097.

18. Melamed N., Yogev Y., Meizner I., Mashiach R., Pardo J., Ben-Haroush A. Prediction of fetal macrosomia: effect of sonographic fetal weight-estimation model and threshold used // Ultrasound Obstet. Gynecol. 2011. Vol. 38, N 1. P. 74–81. DOI: 10.1002/uog.8930.

19. Nesbitt T.S., Gilbert W.M., Herrchen B. Shoulder dystocia and associated risk factors with macrosomic infants born in California // Am. J. Obstet. Gynecol. 1998. Vol. 179, N 2. P. 476–480. DOI: 10.1016/s0002-9378(98)70382-5.

20. Dildy G.A., Clark S.L. Shoulder dystocia: risk identification // Clin. Obstet. Gynecol. 2000. Vol. 43, N 2. P. 265–282. DOI: 10.1097/00003081-200006000-00005.

21. Gross T.L., Sokol R.J., Williams T., Thompson K. Shoulder dystocia: a fetal-physician risk // Am. J. Obstet. Gynecol. 1987. Vol. 156, N 6. Р. 1408–1418. DOI: 10.1016/0002-9378(87)90008-1. PMID: 3591856.

22. Acker D.B., Sachs B.P., Friedman E.A. Risk factors for shoulder dystocia // Obstet. Gynecol. 1985. Vol. 66, N 6. P. 762–768. PMID: 4069477.

23. Langer O., Berkus M.D., Huff R.W., Samueloff A. Shoulder dystocia: should the fetus weighing greater than or equal to 4000 grams be delivered by cesarean section? // Am. J. Obstet. Gynecol. 1991. Vol. 165, N 4. Pt. 1. P. 831–837. DOI: 10.1016/0002-9378(91)90424-p.

24. Casey B.M., Lucas M.J., Mcintire D.D., Leveno K.J. Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population // Obstet. Gynecol. 1997. Vol. 90, N 6. P. 869–873. DOI: 10.1016/s0029-7844(97)00542-5.

25. Ecker J.L., Greenberg J.A., Norwitz E.R., Nadel A.S., Repke J.T. Birth weight as a predictor of brachial plexus injury // Obstet. Gynecol. 1997. Vol. 89, N 5. Pt. 1. P. 643–647. DOI: 10.1016/s0029-7844(97)00007-0.

26. Bryant D.R., Leonardi M.R., Landwehr J.B., Bottoms S.F. Limited usefulness of fetal weight in predicting neonatal brachial plexus injury // Am. J. Obstet. Gynecol. 1998. Vol. 179, N 3. Pt. 1. P. 686–689. DOI: 10.1016/s0002-9378(98)70065-1.

27. Kolderup L.B., Laros R.K. Jr, Musci T.J. Incidence of persistent birth injury in macrosomic infants: association with mode of delivery // Am. J. Obstet. Gynecol. 1997. Vol. 177, N 1. P. 37–41. DOI: 10.1016/s0002-9378(97)70435-6.

28. Bjørstad A.R., Irgens-Hansen K., Daltveit A.K., Irgens L.M. Macrosomia: mode of delivery and pregnancy outcome // Acta. Obstet. Gynecol. Scand. 2010. Vol. 89, N 5. P. 664–669. DOI: 10.3109/00016341003686099.

29. Mathiesen E.R., Ringholm L., Damm P. Stillbirth in diabetic pregnancies // Best Pract. Res. Clin. Obstet. Gynaecol. 2011. Vol. 25, N 1. P. 105–111. DOI: 10.1016/j.bpobgyn.2010.11.001.

30. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins–Obstetrics. ACOG Practice Bulletin No. 201: pregestational diabetes mellitus // Obstet. Gynecol. 2018. Vol. 132, N 6. P. e228–e248. DOI: 10.1097/AOG.0000000000002960.

31. O’Sullivan J.B., Gellis S.S., Dandrow R.V., Tenney B.O. The potential diabetic and her treatment in pregnancy // Obstet. Gynecol. 1966. Vol. 27, N 5. P. 683–689.

32. Pettitt D.J., Knowler W.C., Baird H.R., Bennett P.H. Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians // Diabetes Care. 1980. Vol. 3, N 3. P. 458–464. DOI: 10.2337/diacare.3.3.458.

33. Karlsson K., Kjellmer I. The outcome of diabetic pregnancies in relation to the mother’s blood sugar level // Am. J. Obstet. Gynecol. 1972. Vol. 112, N 2. P. 213–220. DOI: 10.1016/0002-9378(72)90118-4.

34. National Pregnancy in Diabetes (NPID). Audit Report 2018. England, Wales and the Isle of Man. 2019. [Electronic resource]. URL: https://www.hqip.org.uk/wp-content/uploads/2019/10/National-Pregnancy-in-Diabetes-Audit-Report-2018.pdf.

35. Tennant P.W., Glinianaia S.V., Bilous R.W., Rankin J., Bell R. Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study // Diabetologia. 2014. Vol. 57, N 2. P. 285–294. DOI: 10.1007/s00125-013-3108-5.

36. Seeds J.W., Peng T.C. Does augmented growth impose an increased risk of fetal death? // Am. J. Obstet. Gynecol. 2000. Vol. 183, N 2. P. 316–322; discussion 322–323. DOI: 10.1067/mob.2000.107656.

37. Crowther C.A., Hiller J.E., Moss J.R., McPhee A.J., Jeffries W.S., Robinson J.S.; Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes // N. Engl. J. Med. 2005. Vol. 352, N 24. P. 2477–2486. DOI: 10.1056/NEJMoa042973.

38. Landon M.B., Vickers S. Fetal surveillance in pregnancy complicated by diabetes mellitus: is it necessary? // J. Matern. Fetal. Neonatal. Med. 2002. Vol. 12, N 6. P. 413–416. DOI: 10.1080/jmf.12.6.413.416.

39. Rosenstein M.G., Cheng Y.W., Snowden J.M., Nicholson J.M., Doss A.E., Caughey A.B. The risk of stillbirth and infant death stratified by gestational age in women with gestational diabetes // Am. J. Obstet. Gynecol. 2012. Vol. 206, N 4. P. 309.e1–309.e7. DOI: 10.1016/j.ajog.2012.01.014.

40. Zhang X., Decker A., Platt R.W., Kramer M.S. How big is too big? The perinatal consequences of fetal macrosomia // Am. J. Obstet. Gynecol. 2008. Vol. 198, N 5. P. 517.e1–517.e6. DOI: 10.1016/j.ajog.2007.12.005.

41. Hoffman L., Nolan C., Wilson J.D., Oats J.J., Simmons D. Gestational diabetes mellitus--management guidelines. The Australasian Diabetes in Pregnancy Society // Med. J. Aust. 1998. Vol. 169, N 2. P. 93–97. DOI: 10.5694/j.1326-5377.1998.tb140192.x.

42. Kautzky-Willer A., Bancher-Todesca D., Birnbacher R. Gestationsdiabetes (GDM) [Gestational diabetes mellitus] // Acta. Med. Austriaca. 2004. Vol. 31, N 5. P. 182–184. German. PMID: 15747996.

43. National Collaborating Centre for Women’s and Children’s Health (UK). Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. London: National Institute for Health and Care Excellence (UK), 2015. PMID: 25950069.

44. Diabetes in pregnancy. NICE Clinical Guideline. 2008. No. 63. 43 р. [Electronic resource]. URL: https://www.ascalema.es/wp-content/uploads/2014/08/011KO_Diabetes-in-pregnancy-2008.pdf.

45. Sistema Nazionale per le line guidalinee, ISS Taglio cesareo: una scelta appropriata e consapevole. Seconda parte linea guida 21, Gennaio 2011. Vol. 65. [Electronic resource]. URL: https://www.epicentro.iss.it/itoss/pdf/Taglio%20_Cesareo_seconda.pdf.

46. Kitzmiller J.L., Block J.M., Brown F.M., Catalano P.M., Conway D.L., Coustan D.R. et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care // Diabetes Care. 2008. Vol. 31, N 5. P. 1060–1079. DOI: 10.2337/dc08-9020.

47. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins–Obstetrics. ACOG Practice Bulletin No. 201: pregestational diabetes mellitus // Obstet. Gynecol. 2018. Vol. 132, N 6. P. e228–e248. DOI: 10.1097/AOG.0000000000002960.

48. Colorado Clinical Guidelines. Gestational Diabetes Guidelines 2006. Vol. 6. [Electronic resource]. URL: http://www.cdphe.state.co.us/pp/diabetes/index.html.

49. Bismuth E., Bouche C., Caliman C., Lepercq J., Lubin V., Rouge D. et al. Management of pregnancy in women with type 1 diabetes mellitus: guidelines of the French-Speaking Diabetes Society (Société francophone du diabète [SFD]) // Diabet. Metab. 2012. Vol. 38, N 3. P. 205–216. DOI: 10.1016/j.diabet.2012.02.010.